The 2025 CPA-EFMC Symposium on Medicinal Chemistry, organized by the Medicinal Chemistry Committee of the Chinese Pharmaceutical Association, was successfully held in Urumqi, Xinjiang Uygur Autonomous Region, on November 29, 2025.
Centered on the theme "Innovative Drug Discovery Driven by Novel Targets and Cutting-Edge Technologies," the symposium brought together leading experts and scholars from China and Europe, including Prof. Rui Moreira from the University of Lisbon, Portugal, among other internationally renowned researchers. The event focused on frontier technologies in medicinal chemistry, emerging trends in drug innovation, and opportunities for global collaboration, with in-depth discussions on AI-assisted drug design, novel target discovery, and precision drug delivery systems. It showcased China's latest scientific achievements and innovation capabilities in the field of medicinal chemistry.
Beyond fostering profound academic exchange and technological synergy between China and Europe, the symposium further strengthened international research collaboration networks, providing significant momentum for global drug innovation and high-quality pharmaceutical development in China. Moving forward, the Chinese Pharmaceutical Association will continue to serve as a key bridge for international academic exchange, advancing China's medicinal chemistry research to the forefront of global science.